Enteral Feeding Devices Market by Product - Global Industry Analysis and Forecast to 2022

Table of Contents

1.      Introduction

1.1.      Report Description

1.2.      Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2.      Executive Summary

2.1.      Key Highlights

3.      Market Overview

3.1.      Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.      Market Dynamics

3.2.1. Drivers

3.2.1.1.   Rising Incidence of Chronic Diseases around the World

3.2.1.2.   Increasing Preference towards Enteral Feeding in Homecare Settings

3.2.1.3.   Rising Geriatric Population Globally

3.2.2. Restraints

3.2.2.1.   Complications Associated with Enteral Feeding Devices

3.2.3. Opportunities

3.2.3.1.   Technological Advancements in Enteral Feeding Devices

4.      Enteral Feeding Devices Market, By Product

4.1.      Introduction

4.2.      Enteral Feeding Devices Market  Assessment and Forecast, By Product, 2012-2022

4.3.      Giving Sets

4.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.4.      Percutaneous Endoscopic Gastronomy Device

4.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.5.      Enteral Feeding Pump

4.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.6.      Nasogastric Tube

4.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.7.      Low Profile Gastrotomy Device

4.7.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.8.      Gastrotomy Tube

4.8.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.      Enteral Feeding Devices Market, By Region

5.1.      Introduction

5.2.      Enteral Feeding Devices Market  Assessment and Forecast, By Region, 2012-2022 ($Million)

5.3.      North America

5.3.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.3.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.3. U.S.

5.3.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.4. Canada

5.3.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.3.5. Mexico

5.3.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.      Europe

5.4.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.4.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.3. Germany

5.4.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.4. France

5.4.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.5. UK

5.4.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.6. Italy

5.4.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.7. Spain

5.4.7.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.8. Russia

5.4.8.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.4.9. Rest of Europe

5.4.9.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.      Asia-Pacific

5.5.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.5.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.3. Japan

5.5.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.4. China

5.5.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.5. Australia

5.5.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.6. India

5.5.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.7. South Korea

5.5.7.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.8. Taiwan

5.5.8.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.5.9. Rest of Asia-Pacific

5.5.9.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.      Rest of the World

5.6.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

5.6.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.3. Brazil

5.6.3.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.4. Turkey

5.6.4.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.5. Saudi Arabia

5.6.5.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.6. South Africa

5.6.6.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.7. United Arab Emirates

5.6.7.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

5.6.8. Others

5.6.8.1.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

6.      Company Profiles

6.1.      Halyard Health, Inc.

6.1.1. Business Overview

6.1.2. Product Portfolio

6.1.3. Key Financials

6.1.4. Strategic Developments

6.2.       Abbott Laboratories Inc.

6.2.1. Business Overview

6.2.2. Product Portfolio

6.2.3. Key Financials

6.2.4. Strategic Developments

6.3.      Amsino International, Inc.

6.3.1. Business Overview

6.3.2. Product Portfolio

6.3.3. Strategic Developments

6.4.      Boston Scientific Corporation

6.4.1. Business Overview

6.4.2. Product Portfolio

6.4.3. Key Financials

6.4.4. Strategic Developments

6.5.      Medtronic plc

6.5.1. Business Overview

6.5.2. Product Portfolio

6.5.3. Key Financials

6.5.4. Strategic Developments

6.6.      CONMED Corporation

6.6.1. Business Overview

6.6.2. Product Portfolio

6.6.3. Key Financials

6.6.4. Strategic Developments

6.7.      Fresenius Kabi AG (a wholly owned subsidiary of Fresenius SE & Co. KGaA)

6.7.1. Business Overview

6.7.2. Product Portfolio

6.7.3. Key Financials

6.7.4. Strategic Developments

6.8.      C. R. Bard, Inc.

6.8.1. Business Overview

6.8.2. Product Portfolio

6.8.3. Key Financials

6.8.4. Strategic Developments

6.9.      Moog Inc.

6.9.1. Business Overview

6.9.2. Product Portfolio

6.9.3. Key Financials

6.9.4. Strategic Developments

6.10.   Danone

6.10.1.    Business Overview

6.10.2.    Product Portfolio

6.10.3.    Key Financials

6.10.4.    Strategic Developments

6.11.   Nestlé Health Science (a part of Nestlé S.A.)

6.11.1.    Business Overview

6.11.2.    Product Portfolio

6.11.3.    Key Financials

6.11.4.    Strategic Developments

6.12.   Cook Group Incorporated

6.12.1.    Business Overview

6.12.2.    Product Portfolio

 

6.12.3.    Strategic Developments

---

List of Tables

Table 1.Global Enteral Feeding Devices Market, By Product ($Million), 2012-2022
Table 2.Giving Sets Market, By Region ($Million), 2012-2022
Table 3.Percutaneous Endoscopic Gastronomy Device Market, By Region ($Million), 2012-2022
Table 4.Enteral Feeding Pump Market, By Region ($Million), 2012-2022
Table 5.Nasogastric Tube Market, By Region ($Million), 2012-2022
Table 6.Low Profile Gastrotomy Device Market, By Region ($Million), 2012-2022
Table 7.Gastrotomy Tube Market, By Region ($Million), 2012-2022
Table 8.Enteral Feeding Devices Market, By Region ($Million), 2012-2022
Table 9.North America Enteral Feeding Devices Market, By Country, 2012-2022 ($Million)
Table 10.North America Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 11.U.S. Enteral Feeding Devices Market, by Product, 2012-2022 ($Million)
Table 12.Canada Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 13.Mexico Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 14.Europe Enteral Feeding Devices Market, By Country, 2012-2022 ($Million)
Table 55.Europe Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 66.Germany Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 77.France Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 18.UK Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 99.Italy Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 20.Spain Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 21.Russia Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 22.Rest of Europe Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 23.Asia-Pacific Enteral Feeding Devices Market, By Country, 2012-2022 ($Million)
Table 24.Asia-Pacific Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 25.Japan Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 26.China Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 27.Australia Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 28.India Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 29.South Korea Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 30.Taiwan Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 31.Rest of Asia-Pacific Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 32.Rest of the World Enteral Feeding Devices Market, By Country, 2012-2022 ($Million)
Table 33.Rest of the World Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 34.Brazil Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 35.Turkey Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 36.Saudi Arabia Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 37.South Africa Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 38.United Arab Emirates Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 39.Others Enteral Feeding Devices Market, By Product, 2012-2022 ($Million)
Table 40.Halyard Health, Inc.: Key Strategic Developments, 2017-2017
Table 41.Abbott Laboratories Inc.: Key Strategic Developments, 2017-2017
Table 42.Amsino International, Inc.: Key Strategic Developments, 2017-2017
Table 43.Boston Scientific Corporation: Key Strategic Developments, 2017-2017
Table 44.Medtronic plc: Key Strategic Developments, 2017-2017
Table 45.CONMED Corporation: Key Strategic Developments, 2017-2017
Table 46.Fresenius Kabi AG: Key Strategic Developments, 2017-2017
Table 47.C. R. Bard, Inc: Key Strategic Developments, 2017-2017
Table 48.Moog Inc.: Key Strategic Developments, 2017-2017
Table 49.Danone: Key Strategic Developments, 2017-2017
Table 49.Nestlé Health Science: Key Strategic Developments, 2017-2017
Table 49.Cook Group Incorporated: Key Strategic Developments, 2017-2017

---

List of Figures

Figure 1.Global Enteral Feeding Devices Market Share, By Product, 2012 & 2022, ($Million)
Figure 2 Enteral Feeding Devices Market, By Region, 2012 & 2022, ($Million)
Figure 3.Halyard Health, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 4.Halyard Health, Inc.: Net Revenue Share, By Segment, 2017
Figure 5.Halyard Health, Inc.: Net Revenue Share, By Geography, 2017
Figure 6.Abbott Laboratories Inc.: Net Revenues, 2017-2017 ($Million)
Figure7. Abbott Laboratories Inc.: Net Revenue Share, By Segment, 2017
Figure8. Abbott Laboratories Inc.: Net Revenue Share, By Geography, 2017
Figure9.Boston Scientific Corporation: Net Revenues, 2017-2017 ($Million)
Figure10.Boston Scientific Corporation: Net Revenue Share, By Segment, 2017
Figure 11.Boston Scientific Corporation: Net Revenue Share, By Geography, 2017
Figure12. Medtronic plc: Net Revenues, 2017-2017 ($Million)
Figure 13.Medtronic plc: Net Revenue Share, By Segment, 2017
Figure 14.Medtronic plc: Net Revenue Share, By Geography, 2017
Figure 15.CONMED Corporation: Net Revenues, 2017-2017 ($Million)
Figure 16.CONMED Corporation: Net Revenue Share, By Segment, 2017
Figure 17.CONMED Corporation: Net Revenue Share, By Geography, 2017
Figure 18.Fresenius Kabi AG: Net Revenues, 2017-2017 ($Million)
Figure 19.Fresenius Kabi AG: Net Revenue Share, By Segment, 2017
Figure 21.Fresenius Kabi AG: Net Revenue Share, By Geography, 2017
Figure 22.C. R. Bard, Inc: Net Revenues, 2017-2017 ($Million)
Figure 23.C. R. Bard, Inc: Net Revenue Share, By Segment, 2017
Figure 24.C. R. Bard, Inc: Net Revenue Share, By Geography, 2017
Figure 25.Moog Inc.: Net Revenues, 2017-2017 ($Million)
Figure 26.Moog Inc.: Net Revenue Share, By Segment, 2017
Figure 27.Moog Inc.: Net Revenue Share, By Geography, 2017
Figure 28.Danone: Net Revenues, 2017-2017 ($Million)
Figure 29.Danone: Net Revenue Share, By Segment, 2017
Figure 30.Danone: Net Revenue Share, By Geography, 2017
Figure 31.Nestlé Health Science: Net Revenues, 2017-2017 ($Million)
Figure 32.Nestlé Health Science: Net Revenue Share, By Segment, 2017
Figure 33.Nestlé Health Science: Net Revenue Share, By Geography, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country